Biocon Management
Management criteria checks 4/4
Biocon's CEO is Siddharth Mittal, appointed in Dec 2019, has a tenure of 4.92 years. total yearly compensation is ₹57.31M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 0.069% of the company’s shares, worth ₹275.38M. The average tenure of the management team and the board of directors is 2.3 years and 3 years respectively.
Key information
Siddharth Mittal
Chief executive officer
₹57.3m
Total compensation
CEO salary percentage | 100.0% |
CEO tenure | 4.9yrs |
CEO ownership | 0.07% |
Management average tenure | 2.3yrs |
Board average tenure | 3yrs |
Recent management updates
Recent updates
Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results
Nov 02Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E
Nov 01Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?
Oct 14These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Sep 20Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors
Jun 29Is Biocon (NSE:BIOCON) A Risky Investment?
Jun 11Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50
Jun 11Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations
May 24Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50
May 23Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?
Mar 20Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next
Feb 12Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price
Jan 23Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price
Jan 03These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Nov 13Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)
Aug 03Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50
Jul 03Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 02Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50
May 26Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)
Mar 28Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly
Feb 26Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate
Dec 17Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?
Sep 05Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 13Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate
May 26CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | ₹14b |
Jun 30 2024 | n/a | n/a | ₹16b |
Mar 31 2024 | ₹57m | ₹57m | ₹10b |
Dec 31 2023 | n/a | n/a | ₹12b |
Sep 30 2023 | n/a | n/a | ₹5b |
Jun 30 2023 | n/a | n/a | ₹4b |
Mar 31 2023 | ₹48m | ₹48m | ₹5b |
Dec 31 2022 | n/a | n/a | ₹4b |
Sep 30 2022 | n/a | n/a | ₹6b |
Jun 30 2022 | n/a | n/a | ₹7b |
Mar 31 2022 | ₹42m | ₹42m | ₹6b |
Dec 31 2021 | n/a | n/a | ₹7b |
Sep 30 2021 | n/a | n/a | ₹7b |
Jun 30 2021 | n/a | n/a | ₹7b |
Mar 31 2021 | ₹43m | ₹43m | ₹7b |
Dec 31 2020 | n/a | n/a | ₹6b |
Sep 30 2020 | n/a | n/a | ₹6b |
Jun 30 2020 | n/a | n/a | ₹7b |
Mar 31 2020 | ₹49m | ₹31m | ₹8b |
Compensation vs Market: Siddharth's total compensation ($USD678.67K) is about average for companies of similar size in the Indian market ($USD590.37K).
Compensation vs Earnings: Siddharth's compensation has been consistent with company performance over the past year.
CEO
Siddharth Mittal (46 yo)
4.9yrs
Tenure
₹57,310,000
Compensation
Mr. Siddharth Mittal, BCom, CA, CPA has been CEO and Director of Biocon Limited since December 1, 2019. He has been Managing Director of Biocon Limited since April 01, 2020 and served as its Joint Managing...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Executive Chairperson | 46yrs | ₹38.43m | 40.49% ₹ 160.6b | |
MD, CEO & Director | 4.9yrs | ₹57.31m | 0.069% ₹ 275.4m | |
Group Chief Executive Officer | 1.2yrs | ₹1.91m | no data | |
Chief Financial Officer | less than a year | no data | no data | |
Head of Operations | 1.6yrs | no data | no data | |
Group Chief Information Officer | 4.2yrs | no data | no data | |
Head of Investor Relations | 2.3yrs | no data | no data | |
Company Secretary & Compliance Officer | 5.3yrs | ₹5.75m | no data | |
Global Head of Communications & Corporate Brand | no data | no data | no data | |
Head of Human Resources | no data | no data | no data | |
Chief Commercial Officer | no data | no data | no data | |
Commercial Head of Biocon Global Generics | no data | no data | 0.019% ₹ 73.6m |
2.3yrs
Average Tenure
54.5yo
Average Age
Experienced Management: BIOCON's management team is considered experienced (2.3 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder & Executive Chairperson | 46yrs | ₹38.43m | 40.49% ₹ 160.6b | |
MD, CEO & Director | 4.9yrs | ₹57.31m | 0.069% ₹ 275.4m | |
Non-Executive Non-Independent Director | 24.3yrs | ₹6.23m | 0.44% ₹ 1.8b | |
Independent Non-Executive Director | 6.3yrs | ₹7.81m | no data | |
Additional Non-Executive Independent Director | 2.6yrs | ₹6.24m | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | less than a year | ₹5.20m | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Independent Director | 1.3yrs | ₹5.70m | no data | |
Non-Executive Director | 3yrs | ₹5.57m | 0.27% ₹ 1.1b | |
Member of Scientific Advisory Board | no data | no data | no data | |
Non-Executive and Independent Director | less than a year | no data | no data |
3.0yrs
Average Tenure
62.5yo
Average Age
Experienced Board: BIOCON's board of directors are considered experienced (3 years average tenure).